Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

Similar documents
Basics of Benzodiazepine Use Disorder. DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Basics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

MEDICATION ALGORITHM FOR ANXIETY DISORDERS

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

Using Benzodiazepines in Primary Care

Anxiety Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM

Managing presenting problems with benzodiazepines. By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation. Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project

WHAT SHOULD WE DO ABOUT BENZODIAZEPINES? Miriam Komaromy, MD Associate Director, Project ECHO August 2014

Treatment of Anxiety (without benzos)

Strategies in Managing Opioid and Benzodiazepine Co-Prescribing

Practical Tools to Successfully Taper Prescription Opioids. Melissa Weimer, DO, MCR

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

Mixing and Matching: Layering Medications as Family Physicians

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

Treating Anxiety Disorders. Adil Virani, BSc (Pharm), Pharm D, FCSHP

COMMONLY PRESCRIBED PSYCHOTROPIC MEDICATIONS NAME Generic (Trade) DOSAGE KEY CLINICAL INFORMATION Antidepressant Medications*

ANXIETY: FAST FACTS AND SKILLS FOR THE PRIMARY CARE PHYSICIAN

11/1/2010. Psychology 472 Pharmacology of Psychoactive Drugs. Listen to the audio lecture while viewing these slides

Session 2: Mental Health A: Alcohol Dependency: The Pharmacist s Role in Detox and Treatment 1:45pm - 2:45pm

Difficult Conversations

Identification and Management of Benzodiazepine and Z-drug abuse

SCENARIOS IN SUBSTANCE MISUSE. By Dr Gideon Felton Consultant Psychiatrist and Clinical Lead

OLDER ADULTS & DEPRESCRIBING: TREATMENT

Vistaril ( hydroxyzine ) is a non-addictive antihistamine medication. This drug is used to relieve the itching caused by allergies and to control the

Sedatives and Hypnotics. Ahmad Al-Tarifi. Zahra Khalil. Pharmacology. 1 P a g e

USUAL DOSE OF XANAX. Usual Dose Of Xanax

Benzodiazepines. Benzodiazepines

Antidepressant Medication Therapy in Primary Care July 25, 2013

Friend or Foe? Review of the Regulations & Benefits: Risk Profiles of the Benzodiazepines

Disclosures. Objectives. Symptoms of fear. The Fifteen Minute Hour: Psychotherapy & Medications for Anxiety Management in Primary Care 4/5/18

Tapering Opioids Best Practices*

Anxiolytic & Hypnotic Drugs. Asst Prof Dr Inam S Arif

Ativan cause elevated liver enzymes

For: NEON Primary Healthcare Providers By: Michelle Romero, DO June 2013

BOOTS ON THE GROUND CRUCIAL CONVERSATIONS RELATED TO MEDICATION TAPERING

ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS

Pharmacotherapy of Anxiety Disorders (GAD, Panic, & SAD) Declaration of Interests

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

Buprenorphine 2.0: I have my waiver, now what? Dr. Ritu Bhatnagar, M.D., M.P.H. Dr. John Ewing, M.D., FASAM. Disclosures

Anxiety Disorders.

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.

Disclosures. Overview of Workshop. Objectives. Medical Care of Vulnerable and Underserved Populations: Advanced Cases in Anxiety and Depression

BENZODIAZEPINES: WHAT YOU DON T KNOW CAN HURT YOU

Multiple Choice Questions

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

CHILDHOOD/ADOLESCENT ANXIETY DISORDERS: EVALUATION AND TREATMENT

Can klonopin help withdrawal opiates

ALCOHOL USE DISORDER WITHDRAWAL MANAGEMENT AND LONG TERM TREATMENT ANA HOLTEY, MD ADDICTION MEDICINE FELLOW UNIVERSITY OF UTAH HEALTH

Sedative / Hypnotics

DRIVING, DVLA, AND ADVISING PATIENTS: TOP TIPS

DRIVING, DVLA, AND ADVISING PATIENTS: TOP TIPS

An algorithm for medication in the treatment of Complex PTSD

8/15/17. Managing Psychiatric Conditions in Primary Care Beyond the Basics. Speaker s Biography. Situation

Dosage xanax to stop drinking

Benzodiazepines. CRIT program May Alex Walley, MD, MSc Assistant Professor of Medicine Boston University School of Medicine

Opioid Use Disorder Treatment: Buprenorphine Treatment Basics

Managing presenting alcohol users an Introduction to SPECTRUM (CRI) By Dr Gideon Felton MRCPsych Consultant Psychiatrist and Clinical Lead

The fact that your asking your doctor for a drug like Valium by name is enough to raise alarms that your just drug seeking. People like...

Treating Pain and Depression

Best Practices in Prescribing Benzodiazepines. Michael Carlisle, DO Medical Director University Hospitals Geauga Medical Center

ANTICONVULSANTS IN ALCOHOL WITHDRAWAL TREATMENT: A BETTER WAY?

Canadian Guideline for Opioids for Chronic Non-Cancer Pain. Speaker Disclosure. Objectives. Canadian Guideline for Opioids for Chronic Non-Cancer Pain

Alcohol Use in the Elderly

Tapering off.5 xanax. Tapering off.5 xanax

Tapering off ativan.5

1/20/2017. Benzodiazepines Overuse. Pharmacist Objectives. Technician Objectives. A Bit of History. Benzodiazepines: Mechanism of Action

DRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS

An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT

Medications For Alcohol Use Disorder

Managing Pain in the Patient with Opioid Use Disorder: Inpatient Management. Melissa Weimer, DO, MCR Oregon Health & Science University

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Psychiatric Medication Guide

Assessing and Treating Cooccurring

Psychoactive Medications. Alya Reeve, MD Carla Fedor, RN, CDDN Continuum of Care Project

Mental Health Nursing: Anxiety Disorders. By Mary B. Knutson, RN, MS, FCP

Universal Precautions and Opioid Risk. Assessment. Questions: How often do you screen your patients for risk of misuse when prescribing opioids?

Mucky Meds: A (practical) approach the nightmare med list. Michelle Gibson, MD, CCFP (COE), FCFP and Erin Beattie, MD, CCFP

Safe Alprazolam Prescribing and Benzodiazepine Monitoring Program

What You Need to Know About Benzodiazepines & Other Anxiety Drugs

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan

POLYSUBSTANCE USE IN THE TREATMENT OF OPIOID USE DISORDER WITH BUPRENORPHINE

7/7/2016 Journal of the American Medical Association,

Management of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013

Common Psychiatric Conditions in Children. Steven Klamerus, M.D. Child and Adolescent Psychiatrist Marquette General Hospital

1/26/2016. These are my own thoughts! Safe Workplace Safe Workforce Proven benefits of Stay At Work / Return To Work Process (SAW/RTW)

Insomnia: Updates in Medical Management. Michael Newnam M.D.

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Pharmacological Treatment of Anxiety & Depressive Disorders

Acute General Medical and Surgical Admission:

Treatment of Substance Use Disorders in the Real World. Jessica M. Peirce, Ph.D. Johns Hopkins University School of Medicine

Meds and Falls: Keep in Step with your Meds

Treatment of Anxiety Disorders Controlled Substance Workshop. Shonda Phelon MSN, FNP-BC, APMHNP-BC MNA Convention 2011

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

Doreen Wan-Chow-Wah, MD, FRCPC Assistant Professor, Division of Geriatric Medicine, Department of Medicine McGill University Health Center Associate

DISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

Soma (carisoprodol), Soma Compound (carisoprodol and aspirin), Soma Compound w/ Codeine (carisoprodol and aspirin and codeine)

Transcription:

Basics of Benzodiazepine Use Disorder DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

Disclosures Speaker disclosure: One time lecture sponsored by Indivior about overlap of pain and opioid dependence without mention of medication for which I received honorarium. Planner disclosure: None 2 2

Objectives Understand the mechanism of action and pharmacokinetic properties of benzodiazepines Understand that differentiating between benzodiazepine physiologic dependence and benzodiazepine use disorder may be challenging Describe how to safely taper benzodiazepine therapy 3 3

Benzos are positive allosteric modulators Increase the GABA A receptor s affinity for GABA

Benzodiazepine Metabolism Glucuronide Conjugation o Shorter half-life o Inactive metabolites o Safer in liver disease and elderly Lorazepam Oxazepam Temazepam (remember LOT) Oxidation o Longer half-life o More metabolites o Use caution in liver disease Chlordiazepoxide Diazepam Clonazepam

Benzodiazepine Equivalency

Withdrawal Symptoms: occur after 10-21 days of use

Features of a Benzo Use Disorder vs Benzo physiologic dependence Tolerance Withdrawal When severe, these 2 issues can cause problems with their life, ability to cope Benzo dependence alone Benzo use disorder Tolerance Withdrawal Loss of control of use Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Withdrawal Management Soyka, 2017 4-8 weeks to taper, maybe longer, but not too long 10-50% in first week Hospitalize if > 100mg diazepam equivalents Don t withdraw opioids at the same time Adjuncts: pregabalin/gabapentin, carbamazepine, SSRIs, TCAs, antihistamines, melatonin Limited evidence for AEDs, but still consider

Withdrawal Management Calculate benzodiazepine equivalency (http://www.globalrph.com/benzodiazepine_calc.htm) Reduce by 25-30% per day or week, depending on time course Create taper plan based on Time in detox Ability to safely assure taper and monitor patient Other risk factors like opioid use, alcohol use, etc Adjuvant meds Carbamazepine 200mg BID or Divalproic Acid 250mg TID Vistaril 25-50mg QID Buspar 5-10mg TID Trazodone for sleep Consider clonidine or prazosin

Case Example 1 Real case Joe is a 72 yo man with HTN and hyperlipidemia. He developed severe anxiety after retirement approximately 10 years ago and was prescribed lorazepam 1mg BID. He found it helped him at first, but now he feels like it is a crutch and he doesn t like the effect his wife says it has on him. He would like to stop the medication but every time he stops, he becomes sweaty, fearful, anorexic and can not sleep. He would like to stop the medication before he goes on a cruise in 10 days. He has been erratically taking his meds over the last 2 weeks in an attempt to stop them, but has not been able to sleep.

Features of a Benzo Use Disorder vs Benzo physiologic dependence Tolerance Withdrawal Benzo dependence alone Benzo use disorder Tolerance Withdrawal Loss of control of use Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Taper plan Enjoy your vacation on a stable dose of benzos! Start taper when you return Consider transition to clonazepam or diazepam Taper by 10-25% per week depending on how well patient tolerates the withdrawal Start mirtazapine and melatonin for sleep Refer for CBT

Case Example 2 Real case Joanne is a 52 year old female with hx of PTSD and major recurrent depression who seeks care in your primary care clinic for help getting off of benzos. She has been prescribed benzos (diazepam) since age 20 and has tried several times to stop them. She has developed a social phobia about psychiatrists. She can not go longer than 4 hours between doses or she has severe panic, though she does not take them more than prescribed to her Her friend recently drove to FL to pick her up because she was so distraught over her use and inability to stop. She desperately wants to stop and her friend plans to help her and support her.

Features of a Benzo Use Disorder vs Benzo physiologic dependence Tolerance Withdrawal Benzo dependence alone Benzo use disorder Tolerance Withdrawal Loss of control of use Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Taper plan: prolonged taper Stabilize patient over 1-2 weeks on a dose of long acting benzos (clonazepam) mostly equivalent to her current prescription for diazepam Care coordinate with her friend to help manage medication and inform you if there are any issues Start very slow taper of clonazepam by 0.25mg per day every 2 weeks Consider inpatient assistance Add propranolol due to patient avoidance of all other meds Taper takes 1 year and is successful

Case 3: REAL case Jimmy is a 22 year old man with hx of tobacco use who has been ordering a research benzodiazepine (etizolam) from CA for the last year. Total dose of 20mg per day. He also drinks a 6 pack of beer per day. He has received a DWI due to driving while intoxicated. He has had 2 seizures in the past due to attempting to taper his use on his own. He feels restless, anxious, sweaty, and has vomiting. He would like to get back to work for the parks service as soon as possible. His parents have threatened to kick him out of the house if he does not stop his use.

Features of a Benzo Use Disorder vs Benzo physiologic dependence Tolerance Withdrawal Benzo dependence alone Benzo use disorder Tolerance Withdrawal Loss of control of use Continued use despite social or interpersonal issues related to use Giving up other activities due to use No longer fulfilling major life obligations Consistent use despite acknowledgement of harms Wanting to cut down, but not being able Taking in larger amounts and longer than intended

Taper plan Inpatient admission for detoxification Start Depakote 250mg TID, continue 3 weeks Schedule Librium 50-100mg QID x 1 day and then reduce by 25-50mg per day depending on time in detox Continue PRN Librium as well Work with family on safe discharge plan Advise against working or driving for the next week, minimum Start vistaril, buspar, trazodone to help with symptom relief

Alternatives to Benzos for anxiety Gabapentin Prazosin Seroquel Mirtazepine SSRIs Melatonin Vistaril Buspar *List is not in order of preference and not an exhaustive list *Always choose a medication best suited for the specific problem you are attempting to address

References http://www.globalrph.com/benzodiazepine_calc.htm Soyka, Treatment of Benzodiazepine Dependence. NEJM 376; 12. March 23, 2017 http://www.oregonpainguidance.org/app/content/uploads/2016/ 05/Opioid-and-Benzodiazepine-Tapering-flow-sheets.pdf